Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras-mutant lung cancer.
Yuan B, Clowers MJ, Velasco WV, Peng S, Peng Q, Shi Y, Ramos-Castaneda M, Zarghooni M, Yang S, Babcock RL, Chang SH, Heymach JV, Zhang J, Ostrin EJ, Watowich SS, Kadara H, Moghaddam SJ.
Yuan B, et al. Among authors: shi y.
JCI Insight. 2022 Jun 8;7(11):e157788. doi: 10.1172/jci.insight.157788.
JCI Insight. 2022.
PMID: 35471938
Free PMC article.